top
Search terms
Results 1 - 6 of 6 - ordered by :
Ehjournal

Abstract Aims VENTURE-AF is the first prospective randomized trial of uninterrupted rivaroxaban and vitamin K antagonists (VKAs) in patients with non-valvular atrial fibrillation (NVAF) undergoing ...

European Heart Journal, Cappato, Riccardo, Marchlinski, Francis E., Hohnloser, Stefan H., Naccarelli, Gerald V., Xiang, Jim, Wilber, David J., Ma, Chang-Sheng, Hess, Susanne, Wells, Darryl S., Juang, ...

Date : 21/07/2015 Item size : 303748 bytes
Ehjournal

[...]there are persuasive data indicating that AF complicating AMI not only increases the risk for ischaemic stroke during hospitalization but also during follow-up. Introduction Atrial fibrillation ...

European Heart Journal, Schmitt, Joern, Duray, Gabor, Gersh, Bernard J., Hohnloser, Stefan H.

Date : 01/05/2009 Item size : 323928 bytes
Ehjournal

Aims X-VeRT is the first prospective randomized trial of a novel oral anticoagulant in patients with atrial fibrillation undergoing elective cardioversion. Methods and results We assigned 1504 ...

European Heart Journal, Cappato, Riccardo, Ezekowitz, Michael D., Klein, Allan L., Camm, A. John, Ma, Chang-Sheng, Le Heuzey, Jean-Yves, Talajic, Mario, Scanavacca, Maurício, Vardas, Panos E., ...

Date : 14/12/2014 Item size : 278462 bytes
Ehjournal

[...]there are persuasive data indicating that AF complicating AMI not only increases the risk for ischaemic stroke during hospitalization but also during follow-up. Introduction Atrial fibrillation ...

European Heart Journal, Schmitt, Joern, Duray, Gabor, Gersh, Bernard J., Hohnloser, Stefan H.

Date : 01/05/2009 Item size : 331567 bytes
Ehjournal

Abstract Aims X-VeRT is the first prospective randomized trial of a novel oral anticoagulant in patients with atrial fibrillation undergoing elective cardioversion. Methods and results We assigned ...

European Heart Journal, Cappato, Riccardo, Ezekowitz, Michael D., Klein, Allan L., Camm, A. John, Ma, Chang-Sheng, Le Heuzey, Jean-Yves, Talajic, Mario, Scanavacca, Maurício, Vardas, Panos E., ...

Date : 14/12/2014
Ehjournal

Abstract Aims VENTURE-AF is the first prospective randomized trial of uninterrupted rivaroxaban and vitamin K antagonists (VKAs) in patients with non-valvular atrial fibrillation (NVAF) undergoing ...

European Heart Journal, Cappato, Riccardo, Marchlinski, Francis E., Hohnloser, Stefan H., Naccarelli, Gerald V., Xiang, Jim, Wilber, David J., Ma, Chang-Sheng, Hess, Susanne, Wells, Darryl S., Juang, ...

Date : 21/07/2015 Item size : 330013 bytes